Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aladdin: DTaP-IPV Booster in Healthy Children
NCT04618640Phase 3Unknown
- Sponsor
- Boryung Biopharma
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed) in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Boryung Biopharma. Status: unknown.
02
Drugs
diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed)
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT04618640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04618640.